New research reveals the presence of adaptive immune cells, αβ T cells, within the subfornical organ (SFO) in the brain, challenging previous assumptions.
Traditionally, the brain was considered immune-privileged, but this study shows specialized CD4+ T cells in the brain tissue, distinct from meningeal immune cells.
The SFO, lacking a typical blood-brain barrier, provides a niche for T cells expressing unique genes like CXCR6, crucial for their retention within the brain.
These brain-resident T cells produce interferon-gamma, impacting neuronal activity and behaviors in a homeostatic context.
The gut microbiome and adipose tissue play a role in priming these T cells before their migration to the brain, suggesting bidirectional gut-brain and fat-brain axes.
Manipulation of gut microbiota or adipose tissue composition affects T cell numbers in the brain, demonstrating systemic influence over CNS immune surveillance.
Identification of CXCR6 as a key molecule offers potential therapeutic avenues in neurological diseases by modulating immune cell localization.
The study highlights the impact of adaptive immunity on behavior regulation, linking peripheral immune milieu to mood, cognition, and adaptive behaviors.
The research paves the way for understanding immune-brain communication and its implications in neuropsychiatric disorders and neuroinflammation.
The presence of these resident T cells in the SFO opens new possibilities for therapeutic interventions targeting tissue-resident immune compartments in the CNS.